Sign in

CIK 0001808805

  • Non-accelerated filer
  • Smaller reporting company

Nautilus Biotechnology, Inc.

Sign in to watch
Ticker
NAUT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Entity type
Operating
EIN
981541723
Phone
+1 206-333-2001
Business address
2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
Former names
ARYA Sciences Acquisition Corp III
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Senior VP, Product Development bought 15,000 shares at an average $2.03 ($30,399)
  13. 4 Open-market buy Chief People Officer bought 30,000 shares at $2.03 ($60,765)
  14. 4 Open-market buy Senior VP, Product Development bought 75,000 shares at an average $2.18 ($163,198)
  15. 4 Open-market buy CFO and Treasurer bought 17,500 shares at $2.30 ($40,219)
  16. 4 Open-market buy General Counsel bought 10,000 shares at an average $2.84 ($28,433)
  17. 4 Open-market buy CEO, President, and Secretary bought 50,000 shares at an average $2.92 ($146,090)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy CFO and Treasurer bought 5,500 shares at $2.75 ($15,124)

Page 4 of 8 · 141 filings